Loading...

GSK plc

GS7.DEXETRA
Healthcare
Drug Manufacturers - General
20.60
4.12(25.00%)
German Market opens in 7h 54m

GSK plc (GS7.DE) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio13.99
EPS (TTM)$1.19
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

GS7.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GS7.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.99 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
7.40%
3-Year Change
1.15%
5-Year Change
38.40%
All-Time (Max) Change
11.93%

Contact Information

44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

900,960 Employees
IPO DateDec 1, 2003
CountryGB

Frequently Asked Questions